Announcements Trials

Browse Landscape

Phase

Phase 2 44 Phase 1 12 Phase 1/2 10 Phase NA 4 Phase 3 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Neoplasm, Residual 3 Small Cell Lung Carcinoma 2 Lymphoma, Extranodal NK-T-Cell 2 Burkitt Lymphoma 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Retinoblastoma 1 Medulloblastoma 1 Mediastinal Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lymphohistiocytosis, Hemophagocytic 1 Leukemia, Myeloid, Acute 1 Intracranial Germ Cell Tumors 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Cyclophosphamide 2 temsirolimus 1 prednylidene 1 ibrutinib 1 acalabrutinib 1 Vincristine 1 Thiotepa 1 Thalidomide 1 Rituximab 1 Radiotherapy 1 Prednisone 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cytarabine 1 Cisplatin 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, Mantle-Cell × Etoposide × Clear all

NCT02858804 2026-02-11

BDH-MCL01

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡